Clin Drug Invest. 2005;25(9):579-587. Acarbose was well tolerated by the majority of patients in spite of the very high dosing regimen used. Median treatment duration was similar for acarbose and ...

Objective and design: This post-marketing surveillance study collected data on the efficacy and tolerability of acarbose in patients with insulin-treated type 2 diabetes mellitus and, in ...